` SCP (Scope Fluidics SA) vs WIG20 Comparison - Alpha Spread

S
SCP
vs
W
WIG20

Over the past 12 months, SCP has underperformed WIG20, delivering a return of -10% compared to the WIG20's +21% growth.

Stocks Performance
SCP vs WIG20

Loading

Performance Gap
SCP vs WIG20

Loading
SCP
WIG20
Difference
www.alphaspread.com

Performance By Year
SCP vs WIG20

Loading
SCP
WIG20
Add Stock

Competitors Performance
Scope Fluidics SA vs Peers

Scope Fluidics SA
Glance View

Market Cap
418.2m PLN
Industry
Health Care

Scope Fluidics SA engages in the research and development in the field of healthcare. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 30 full-time employees. The company went IPO on 2017-08-16. The firm focuses on diagnostic and med-tech solutions. The company develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The firm provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.

SCP Intrinsic Value
37.07 PLN
Overvaluation 76%
Intrinsic Value
Price
S
Back to Top